Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Expression of Recombinant Htlv-II
Dolby, Nichol
Hawaii Biotech, Inc., Aiea, HI, United States
Search grants from Nichol Dolby
Search grants from Hawaii Biotech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neurodevelopment and Vector-borne Diseases: Building Research Capacity in the Tropics
Pharmacological Management of Delirium
R90 Training the Global Ready Scholar (9 of 10)RL9
Distribution of Body Fat and Cancer Risk in Women
Brazil's Direct Action Land Reform Movement: Environmental Impacts and Socio-Spatial Dynamics
Recently added grants:
HIV-Related Changes to the Central-Autonomic Network and Associated Risk for Hypertension
Neural control of breathing
Role of protein-S-glutathionylation in endothelial dysfunction and atherosclerosis
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CP005695-002
Application #
3626522
Study Section
Project Start
1991-03-28
Project End
Budget Start
1991-03-28
Budget End
1991-04-30
Support Year
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Hawaii Biotech, Inc.
Department
Type
DUNS #
113226823
City
Aiea
State
HI
Country
United States
Zip Code
96701
Related projects
NIH 1991
N43 CP
Cloning and Expression of Recombinant Htlv-II
Dolby, Nichol / Hawaii Biotech, Inc.
NIH 1990
N43 CP
Cloning and Expression of Recombinant Htlv-II
Dolby, Nichol / Hawaii Biotech, Inc.
Comments
Be the first to comment on Nichol Dolby's grant